Skip to main content

Table 1 Patient demographics and clinical data

From: Efficacy and safety of selective renal arterial embolization in renal angiomyolipoma: a prospective single-center study

Variables

Data, N (%)

No. of patients

33

Gender

 

Male

9 (27.3)

Female

24 (72.7)

Type of AMLs

 

Single

15 (45.5)

Multiple

18 (54.5)

Laterality of AMLs

 

Unilateral

17 (51.5)

Right

9 (27.3)

Left

8 (24.2)

Bilateral

16 (48.5)

TSC status

 

Yes

12 (36.4)

No

21 (63.6)

Other comorbidities

 

Diabetes mellitus (DM)

6 (18.2)

HTN

10 (30.3)

Hepatic

1 (3)

Cardiac

1 (3)

Past history

 

Previous SAE

4 (12.1)

Need for blood transfusion

 

No need

7 (21.2)

Need

26 (78.8)

TSC features

12

Family history

2 (16.7)

Vogt triad

12 (100)

Seizures

12(100)

Intellectual disability

9 (75)

Adenoma sebaceum

10 (83.3)

Associated other lesions

12

Cortical or subependymal brain tubers

12 (100)

Pulmonary LAMs

2 (16.7)

Hepatic AMLs

8 (66.7)

No. of embolized renal AMLs with SAE

35

Type of AMLs

 

TSC-associated

15 (42.9)

Sporadic

20 (57.1)

Classification of AMLs

 

Fat rich

33 (94.3)

Fat-poor

2 (5.7)

Fat-invisible

0

Side of AMLs

 

Right

20 (57.1)

Left

15 (42.9)

Presentation of AMLs

 

Asymptomatic

5 (14.3)

Symptomatic

30 (85.7)

Type of SAE

 

Prophylactic

3 (8.6)

Emergency

29 (82.8)

Pre-operative

3 (8.6)

Indications

 

Pain

35 (100)

Size

35 (100)

Composition

4 (11.4)

Bleeding symptoms

30 (85.7)

Hematuria

12 (34.3)

Intra-lesional bleeding

27 (77.1)

Retro-peritoneal bleeding

20 (57.1)

Presence of vascular anomalies

 

Yes

34 (97.1)

Micro-aneurysms

9 (25.7)

Aneurysms

24 (68.5)

AVM

1 (2.9)

No

1 (2.9)

Embolic material used

 

Microcoils

20 (57.2)

Microspheres

4 (11.4)

Microspheres and microcoils

7 (20)

Absolute alcohol and microcoils

4 (11.4)